| visual processing |
phenotype |
5 |
5 |
visual processing, visual-processing |
| visual working memory |
phenotype |
2 |
2 |
VWM |
| Visuospatial deficits |
phenotype |
4 |
4 |
poor performance on visuospatial tasks, visuospatial deficits, visuospatial impairment, visuospatial task deficits |
| vital signs |
phenotype |
5 |
2 |
physiological measures |
| Vitamin A |
drug |
3 |
1 |
Retinol, vitamin A |
| vitamin B12 |
drug |
6 |
1 |
B12, cobalamin, vit B12 |
| Vnn1 |
gene |
2 |
2 |
Vanin1 |
| vocabulary |
phenotype |
5 |
1 |
vocabulary score |
| vodka |
drug |
4 |
3 |
10 proof vodka, 100 proof Absolute ® vodka, 100-proof vodka, Absolute ® vodka, Bacardi, Grey Goose, Smirnoff Blue Label®, vodka |
| volatile anesthetic |
drug |
2 |
1 |
volatile agents, volatile anesthetics |
| voltage-gated calcium channel |
drug |
6 |
5 |
VGCC, voltage‑gated Ca2+ channel |
| voluntary alcohol consumption |
phenotype |
16 |
11 |
per capita total alcohol consumption, state per capita alcohol consumption, total alcohol, total intake, typical alcohol quantity, typical quantity of alcohol consumption |
| voluntary ethanol consumption |
phenotype |
12 |
8 |
alcohol consumption, ethanol consumption, ethanol-seeking, mean weekly alcohol consumption, outcome variable, voluntary consumption of ethanol, voluntary drinking ethanol |
| volunteers |
cohort |
3 |
1 |
participants, study participants |
| vomiting |
phenotype |
6 |
4 |
|
| VRK2 |
gene |
3 |
2 |
VRK serine/threonine kinase 2 |
| VSIG4 |
gene |
3 |
2 |
|
| VSVg |
drug |
2 |
1 |
|
| vulnerability |
phenotype |
9 |
7 |
|
| waist circumference |
phenotype |
9 |
7 |
WC, waist |
